- Analytica Investor
- Posts
- ๐ Real Assets Over Growth?
๐ Real Assets Over Growth?
An oral vaccine biotech surged +110% after stepping onto a global bioinnovation stage

Good Morning Investors,
Investors are using real assets as a hedge while digesting political and policy related headlines tied to the Federal Reserve, rather than chasing momentum in growth or technology leaders.
Commodity exposed juniors and health related names, including biotech and obesity focused plays, appear positioned for near term activity as positioning adjusts to macro uncertainty.
Volatility remains possible as policy clarity evolves, making earnings updates and confirmation from economic data the next key drivers for direction.
Matthias Schneider
Editor at Analytica Investor